Long Term Follow Up for CTSN Mitral Valve Repair Studies
Condition(s) studied
Investigational drug(s) / intervention(s)
MV Repair: Participants underwent mitral valve repair with annuloplasty and a sub-valvular procedure for severe tethering.
MV Replacement: Participants underwent mitral valve replacement and complete preservation of the sub-valvular apparatus.
CABG: Participants underwent coronary artery bypass grafting
Study summary
This study is a continuation of two previous studies --- the Severe Ischemic Mitral Regurgitation (SMR) Trial (NCT00807040) and the Moderate Ischemic Mitral regurgitation (MMR) Trial (NCT00806988) --- to learn more about patients' health 5-10 years after their mitral valve surgeries. The investigators will collect long-term health information on SMR and MMR trial participants using electronic medical records, patient and/or family input, public records, and healthcare- and vital status-related databases.
Eligibility
Primary outcome measure(s)
- Survival — up to 10 years post-surgery (at the time of registry data transfer)
All-cause mortality will be assessed.
Trial sites (24)
| Facility | City | Region | Status |
|---|---|---|---|
| University of Southern California | Los Angeles | California | |
| Emory University | Atlanta | Georgia | |
| University of Maryland | Baltimore | Maryland | |
| Suburban Hospital | Bethesda | Maryland | |
| Brigham and Women's Hospital | Boston | Massachusetts | |
| Columbia University Medical Center | New York | New York | |
| Montefiore Einstein Heart Center | The Bronx | New York | |
| Mission Hospital | Asheville | North Carolina | |
| Duke University | Durham | North Carolina | |
| East Carolina Heart Institute | Greenville | North Carolina | |
| Cleveland Clinic Foundation | Cleveland | Ohio | |
| Ohio State University | Columbus | Ohio | |
| University of Pennsylvania | Philadelphia | Pennsylvania | |
| Baylor Research Institute | Plano | Texas | |
| University of Virginia Health Systems | Charlottesville | Virginia | |
| Inova Heart and Vascular Institute | Falls Church | Virginia | |
| University of Alberta Hospital | Edmonton | Alberta | |
| Sunnybrook Health Science Centre | Toronto | Ontario | |
| Saint Michael's Hospital | Toronto | Ontario | |
| Toronto General Hospital | Toronto | Ontario | |
| Montreal Heart Institute | Montreal | Quebec | |
| Centre Hospitalier de l'Université de Montréal | Montreal | Quebec | |
| Hôpital du Sacré-Cœur de Montréal | Montreal | Quebec | |
| Institut Universitaire de Cardiologie de Quebec (Hopital Laval) | Québec | Canada |
More Icahn School of Medicine at Mount Sinai trials in Canada
Other trials for the same condition
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT03066050 on ClinicalTrials.gov ↗ ← All trials in Canada